Revelation Biosciences (REVB) Assets (2020 - 2026)
Revelation Biosciences (REVB) posted Assets of $12.5 million for Q2 2026, up 131.7% from $5.4 million a year earlier but down 16.9% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Revelation Biosciences' Assets came in at $11.58 million, up 74.9% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -31.0% (FY2020 to FY2025).
- In prior years, Revelation Biosciences' Assets was $6.62 million in FY2024 (-45.8%), $12.21 million in FY2023 (+121.9%), $5.5 million in FY2022 (+169.5%) and $2.04 million in FY2021 (-97.2%).
- Quarterly Assets has run from a low of $2.04 million in Q4 2021 to a high of $73.56 million in Q3 2021 over five years.
- On a year-over-year basis, Assets has increased in each of the last four quarters, with growth averaging 43.6% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q2 2023, with growth of 286.1%; the weakest was Q4 2021, with a decline of 97.2%.
- According to Business Quant data, Assets for the three prior quarters was $15.04 million (Q1 2026), $11.58 million (Q4 2025) and $12.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Revelation Biosciences | 3.36 Mn | -45.66 Mn | - | 12.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.50 Mn |
| Mar 31, 2026 | 15.04 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 12.86 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Mar 31, 2025 | 3.97 Mn |
| Dec 31, 2024 | 6.62 Mn |
| Sep 30, 2024 | 6.74 Mn |
| Jun 30, 2024 | 12.27 Mn |
| Mar 31, 2024 | 14.70 Mn |
| Dec 31, 2023 | 12.21 Mn |
| Sep 30, 2023 | 14.22 Mn |
| Jun 30, 2023 | 16.04 Mn |
| Mar 31, 2023 | 18.12 Mn |
| Dec 31, 2022 | 5.50 Mn |
| Sep 30, 2022 | 6.60 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 7.98 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 73.56 Mn |
API Access
Revelation Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();